1. Duan H, Ge W, Zhang A, Xi Y, Chen Z, Luo D, et al: Transcriptome analyses reveal molecular mechanisms underlying functional recovery after spinal cord injury. Proc Natl Acad Sci U S A. 2015,112(43).
2. Alizadeh A, Dyck SM, Kataria H, Shahriary GM, Nguyen DH, Santhosh KT, Karimi-Abdolrezaee S: Neuregulin-1 positively modulates glial response and improves neurological recovery following traumatic spinal cord injury. Glia 2017, 65(7):1152-1175.
3. Liu S, Chen Z: Employing Endogenous NSCs to Promote Recovery of Spinal Cord Injury. Stem Cells Int 2019, 2019:1958631.
4. Rosich K, Hanna BF, Ibrahim RK, Hellenbrand DJ, Hanna A: The Effects of Glial Cell Line-Derived Neurotrophic Factor after Spinal Cord Injury. J Neurotrauma 2017, 34(24):3311-3325.
5. Amanat M, Vaccaro AR: Reducing alpha-synuclein in spinal cord injury: A new strategy of treatment. J Neurosci Res 2019, 97(7):729-732.
6. Goedert M: Alzheimer's and Parkinson's diseases: The prion concept in relation to assembled Abeta, tau, and alpha-synuclein. Science 2015, 349(6248):1255555.
7. Rocha EM, De Miranda B, Sanders LH: Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson's disease. Neurobiol Dis 2018, 109(Pt B):249-257.
8. Feng GY, Liu J, Wang YC, Wang ZY, Hu Y, Xia QJ, Xu Y, Shang FF, Chen MR, Wang F et al: Effects of Alpha-Synuclein on Primary Spinal Cord Neurons Associated with Apoptosis and CNTF Expression. Cell Mol Neurobiol 2017, 37(5):817-829.
9. Wang H, Yu Q, Ding X, Hu X, Hou K, Liu X, Nie S, Xie M: RNA-seq based elucidation of mechanism underlying Ganoderma atrum polysaccharide induced immune activation of murine myeloid-derived dendritic cells. Journal of Functional Foods 2019, 55:104-116.
10. Ma Q, Chen C, Zeng Z, Zou Z, Li H, Zhou Q, Chen X, Sun K, Li X: Transcriptomic analysis between self- and cross-pollinated pistils of tea plants (Camellia sinensis). BMC Genomics 2018, 19(1):289.
11. Balta EA, Wittmann MT, Jung M, Sock E, Haeberle BM, Heim B, von Zweydorf F, Heppt J, von Wittgenstein J, Gloeckner CJ et al: Phosphorylation Modulates the Subcellular Localization of SOX11. Front Mol Neurosci 2018, 11:211.
12. Flores-Cuadrado A, Saiz-Sanchez D, Mohedano-Moriano A, Martinez-Marcos A, Ubeda-Banon I: Neurodegeneration and contralateral alpha-synuclein induction after intracerebral alpha-synuclein injections in the anterior olfactory nucleus of a Parkinson's disease A53T mouse model. Acta Neuropathol Commun 2019, 7(1):56.
13. Braak H, Del Tredici K: Neuroanatomy and pathology of sporadic Parkinson's disease. Adv Anat Embryol Cell Biol. 2009, 201:1-119.
14. Uchihara T, Giasson BI: Propagation of alpha-synuclein pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies. Acta Neuropathol 2016, 131(1):49-73.
15. Xiang X, Yu Y, Tang X, Chen M, Zheng Y, Zhu S: Transcriptome Profile in Hippocampus During Acute Inflammatory Response to Surgery: Toward Early Stage of PND. Front Immunol 2019, 10:149.
16. Anglister L, Cherniak M, Lev-Tov A: Ascending pathways that mediate cholinergic modulation of lumbar motor activity. J Neurochem 2017, 142 Suppl 2:82-89.
17. Li DJ, Fu H, Tong J, Li YH, Qu LF, Wang P, Shen FM: Cholinergic anti-inflammatory pathway inhibits neointimal hyperplasia by suppressing inflammation and oxidative stress. Redox Biol 2018, 15:22-33.
18. Di Cesare Mannelli L, Zanardelli M, Ghelardini C: Nicotine is a pain reliever in trauma- and chemotherapy-induced neuropathy models. Eur J Pharmacol 2013, 711(1-3):87-94.
19. Hoover DB: Cholinergic modulation of the immune system presents new approaches for treating inflammation. Pharmacol Ther 2017, 179:1-16.
20. Kiguchi N, Kobayashi D, Saika F, Matsuzaki S, Kishioka S: Inhibition of peripheral macrophages by nicotinic acetylcholine receptor agonists suppresses spinal microglial activation and neuropathic pain in mice with peripheral nerve injury. J Neuroinflammation 2018, 15(1):96.
21. Maurer SV, Williams CL: The Cholinergic System Modulates Memory and Hippocampal Plasticity via Its Interactions with Non-Neuronal Cells. Front Immunol 2017, 8:1489.
21. Maurer SV, Williams CL: The Cholinergic System Modulates Memory and Hippocampal Plasticity via Its Interactions with Non-Neuronal Cells. Front Immunol 2017, 8:1489.
22. Liu Z, Wang L, Lv Z, Zhou Z, Wang W, Li M, Yi Q, Qiu L, Song L: The Cholinergic and Adrenergic Autocrine Signaling Pathway Mediates Immunomodulation in Oyster Crassostrea gigas. Front Immunol 2018, 9:284.
23. Sui G, Fry CH, Montgomery B, Roberts M, Wu R, Wu C: Purinergic and muscarinic modulation of ATP release from the urothelium and its paracrine actions. Am J Physiol Renal Physiol 2014, 306(3):F286-298.
24. Jiang W, St-Pierre S, Roy P, Morley BJ, Hao J, Simard AR: Infiltration of CCR2+Ly6Chigh Proinflammatory Monocytes and Neutrophils into the Central Nervous System Is Modulated by Nicotinic Acetylcholine Receptors in a Model of Multiple Sclerosis. J Immunol 2016, 196(5):2095-2108.
24. Jiang W, St-Pierre S, Roy P, Morley BJ, Hao J, Simard AR: Infiltration of CCR2+Ly6Chigh Proinflammatory Monocytes and Neutrophils into the Central Nervous System Is Modulated by Nicotinic Acetylcholine Receptors in a Model of Multiple Sclerosis. J Immunol 2016, 196(5):2095-2108.
25. Shin SS, Dixon CE: Alterations in Cholinergic Pathways and Therapeutic Strategies Targeting Cholinergic System after Traumatic Brain Injury. J Neurotrauma 2015, 32(19):1429-1440.
26. Kistemaker LE, Bos IS, Hylkema MN, Nawijn MC, Hiemstra PS, Wess J, Meurs H, Kerstjens HA, Gosens R: Muscarinic receptor subtype-specific effects on cigarette smoke-induced inflammation in mice. Eur Respir J 2013, 42(6):1677-1688.
27. Thomas GM, Huganir RL: MAPK cascade signalling and synaptic plasticity. Nat Rev Neurosci 2004, 5(3):173-183.
28. Mufson EJ, He B, Ginsberg SD, Carper BA, Bieler GS, Crawford F, Alvarez VE, Huber BR, Stein TD, McKee AC et al: Gene Profiling of Nucleus Basalis Tau Containing Neurons in Chronic Traumatic Encephalopathy: A Chronic Effects of Neurotrauma Consortium Study. J Neurotrauma 2018, 35(11):1260-1271.
29. Pike BR, Hamm RJ: Activating the posttraumatic cholinergic system for the treatment of cognitive impairment following traumatic brain injury.Pharmacol Biochem Behav. 1997,57(4):785-91.
30. De Luca V, Voineskos S, Wong G, Kennedy JL: Genetic interaction between alpha4 and beta2 subunits of high affinity nicotinic receptor: analysis in schizophrenia. Exp Brain Res 2006, 174(2):292-296.
31. Cook LJ, Ho LW, Taylor AE, Brayne C, Evans JG, Xuereb J, Cairns NJ, Pritchard A, Lemmon H, Mann D et al: Candidate gene association studies of the alpha 4 (CHRNA4) and beta 2 (CHRNB2) neuronal nicotinic acetylcholine receptor subunit genes in Alzheimer's disease. Neurosci Lett 2004, 358(2):142-146.
32. Mingarro I, von Heijne G, Whitley P: Membrane-protein engineering.Trends Biotechnol. 1997,15(10):432-7.
33. Squair JW, Ruiz I, Phillips AA, Zheng MMZ, Sarafis ZK, Sachdeva R, Gopaul R, Liu J, Tetzlaff W, West CR et al: Minocycline Reduces the Severity of Autonomic Dysreflexia after Experimental Spinal Cord Injury. J Neurotrauma 2018, 35(24):2861-2871.
34. Basso DM, Beattie MS, Bresnahan JC: A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma. 1995,12:1-21.
35. Li B, Dewey CN: RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics 2011;12:323.
36. Robinson MD, McCarthy DJ, Smyth GK: edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 2010;26:139-40.
37. Xie C, Mao X, Huang J, Ding Y, Wu J, Dong S, et al: KOBAS 2.0: a web server for annotation and identification of enriched pathways and diseases. Nucleic Acids Res 2011;39:W316-22.
37. Xie C, Mao X, Huang J, Ding Y, Wu J, Dong S, et al: KOBAS 2.0: a web server for annotation and identification of enriched pathways and diseases. Nucleic Acids Res 2011;39:W316-22.
38. Sahinkaya FR, Milich LM, McTigue DM: Changes in NG2 cells and oligodendrocytes in a new model of intraspinal hemorrhage. Exp Neurol 2014, 255:113-126.